| Name |
Ziglip 145 mg tablete |
| Former Name |
Zyglip 145 mg tablete |
| Marketing Authorisation Number |
HR-H-432762902 |
| Active Substance |
fenofibrat |
| Composition |
jedna tableta sadrži 145 mg fenofibrata (nanočestice) |
| Pharmaceutical Form |
tableta |
| Manufacturer |
Alkaloid-int d.o.o., Ljubljana, Slovenija |
| Marketing Authorisation Holder |
Alkaloid d.o.o., Slavonska avenija 6 A, Zagreb |
| Marketing Authorisation Date |
06.05.2019 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/607 |
| Registration Number |
381-12-01/30-19-12 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C10AB05 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
